Abstract
Background
Staphylococcus aureus has long been recognized as a major pathogen. Methicillin‐resistant strains of S. aureus (MRSA) and methicillin‐resistant strains of S. epidermidis (MRSE) are among the most prevalent multiresistant pathogens worldwide, frequently causing nosocomial and community‐acquired infections.
Methods
In the present pilot study, we tested a polymerase chain reaction (PCR) method to quickly differentiate Staphylococci and identify the mecA gene in a clinical setting.
Results
Compared to the conventional microbiology testing the real‐time PCR assay had a higher detection rate for both S. aureus and coagulase‐negative Staphylococci (CoNS; 55 vs. 32 for S. aureus and 63 vs. 24 for CoNS). Hands‐on time preparing DNA, carrying out the PCR, and evaluating results was less than 5 h.
Conclusions
The assay is largely automated, easy to adapt, and has been shown to be rapid and reliable. Fast detection and differentiation of S. aureus, CoNS, and the mecA gene by means of this real‐time PCR protocol may help expedite therapeutic decision‐making and enable earlier adequate antibiotic treatment.
Keywords: MRSA, bacterial DNA, PCR, microbiology, Staphylococcus
INTRODUCTION
Staphylococcus aureus has long been recognized as a major pathogen. Immediately upon the introduction of methicillin into clinical use, methicillin‐resistant strains of staphylococci began to appear 1, 2, 3. Methicillin‐resistant strains of S. aureus (MRSA) and S. epidermidis (MRSE) are among the most prevalent multiresistant pathogens worldwide, frequently causing nosocomial and community‐acquired infections 4. The frequencies of both community‐acquired and hospital‐acquired staphylococcal infections and occurrence of MRSA have increased steadily over the last decades. Infections by these strains have now become a serious problem worldwide 5, 6, 7. Approximately 25% of nosocomial isolates of S. aureus are methicillin‐resistant in hospitals in the United States 8.
Prompt, reliable identification of MRSA is crucial to starting appropriate antibiotic therapy and effectively eradicating infection. Early MRSA identification facilitates early contact isolation of patients and prevents unrecognized spread of MRSA within ICUs. Differentiating MRSA from coagulase‐negative staphylococci (CoNS) is also imperative, since the latter often appears as contaminants but can also be a separate cause of infection. Extensive hygienic precautions that are expensive and time‐consuming may be avoided in nonessential cases 9, 10. Unnecessary isolation of patients and needless use of resources could be avoided by specific, quick detection. Hence, the enormous economic burden presented by S. aureus infections could be directly reduced by an improved rapid testing protocol 10.
Standard identification methods and susceptibility tests are usually time‐consuming. Using susceptibility tests according to the standards of the National Committee of Clinical Standards (NCCLS, now Clinical and Laboratory Standards Institute, CLSI) S. aureus resistance to methicillin or oxacillin can be reliably detected 11, 12. Nevertheless, false‐negative or false‐positive results in identification of susceptibility may be observed due to heterogeneous phenotypic expression of methicillin resistance, or to misclassifications with automated susceptibility testing systems and use of latex agglutination kits 9, 13, 14.
The presence of an additional low‐affinity penicillin‐binding protein 2a (PBP2a), which is encoded by the mecA gene, is associated with methicillin resistance in both S. aureus and CoNS 12, 15, 16, 17, 18, 19. Polymerase chain reaction (PCR) to detect the mecA gene as a rapid method for the identification of MRSA has been amply demonstrated 11, 20, 21, 22, 23, 24, 25, 26, 27. Some even consider PCR to be the method of choice for identifying MRSA and other methicillin‐resistant staphylococci 8, 28, 29, 30, 31, 32, 33, 34.
In the present pilot study, we evaluated a PCR‐based method for Staphylococci differentiation and mecA gene identification in comparison to the conventional microbiology. The goal of this approach was to enable accurate and fast differentiation between S. aureus and CoNS, with rapid, specific identification of the mecA gene using a real‐time PCR protocol.
MATERIAL AND METHODS
Study Design
A prospective sample of consecutive microbiologically confirmed cases of MRSA was used for an intraindividual comparison of experimental PCR to a standard microbiologic method. This study was approved by the local ethics committee.
Inclusion criterion was an MRSA‐positive microbiological finding. To identify MRSA‐positive patients, first a routine clinical screening by the conventional microbiology methods was done across all wards of the hospital. Once the microbiology department had identified an MRSA‐positive patient, they informed us immediately. Since the study took place in a clinical setting, it was expected that some patients would no longer be positive using either PCR or conventional microbiology testing due to antibiotic treatment started before the first specimens were collected for this study. After acquisition of written informed consent patients were included in the study. After inclusion patients were monitored until three consecutive microbiological cultures or PCR findings were negative for MRSA or the patient was discharged.
Polyester fiber‐tipped swabs (BD Falcon SWUBE, BD, Heidelberg, Germany) were used for sample acquisition. Sites sampled included trachea, throat, nose, hair, groin, perineum, wound, and drainage. A total of 116 specimens from 12 patients were obtained. Sample bias was minimized, since specimens were acquired in parallel from each sampled location. Therefore, samples were taken from the exact same location: two swabs, one for PCR testing and one for conventional microbiology testing, were held side by side and swiped in parallel over the site. Swabs were analyzed by the conventional microbiology cultures; parallel swabs were analyzed by PCR.
Since the aim of the study was to compare the conventional microbiology testing with PCR‐based technology, each patient sample is treated as an independent biological sample (n = 116).
Conventional Microbiology Cultures
For MRSA screening, specimens were plated on both Columbia sheep blood agar and on mannitol salt agar containing cefoxitin and read after incubation periods of 18–24 and 48 h. Species were identified by characteristic growth morphologies, Gram stain characteristics, catalase activity, and coagulase production. Susceptibility tests were performed via disk diffusion testing with cefoxitin in accordance with the National Committee for Clinical Laboratory Standards criteria described previously 35.
DNA Extraction
For analysis via PCR the swabs were processed immediately after sampling. Bacterial DNA extraction was performed with an automatic preparation device (MagNa Pure LC; Roche, Mannheim, Germany) using the LC‐Microbiology Kit (Roche) according to the manufacturer's recommendations.
In brief, the swabs were incubated in bacterial lysis buffer with Proteinase K at 65°C for 10 min. After an inactivation step at 95°C for 10 min, swabs were centrifuged with the swab extraction tube system (Roche) to separate the lysis buffer from the swab. One hundred microliters of lysis buffer were placed in the MagNa Pure System for automated preparation using the DNA III protocol.
Real‐Time PCR
Two different PCR runs were performed using a real‐time PCR system (LightCycler, Roche).
First, PCR detected and differentiated S. aureus from CoNS using the “Staphylococcus Kit M‐Grade” (Roche) according to the manufacturers’ recommendations. In brief, the test consists of a primer pair specific for the ITS region, the Staphylococcus bacterial genome and specific hybridization probes for S. aureus. Differentiation of S. aureus and CoNS is based on melting curve analysis following the PCR amplification.
Second, PCR detected methicillin resistance (mecA gene) in Staphylococcus spp. using the MRSA Detection Kit (Roche) according to the manufacturers’ recommendations. The kit uses primers and hybridization probes to amplify and ascertain sequence‐specific methicillin resistance associated with the mecA gene. Detection of the mecA gene is carried out by means of amplification‐ and melting curve analysis. Furthermore, the lyzed specimen was spiked with an internal control, then co‐extracted and co‐amplified with the samples of interest. This simultaneous processing of sample DNA and internal control allowed efficient extraction and inhibition control of the PCR workflow.
The reliability of this test has been established in earlier studies, showing high sensitivity of 95.7–100%, with very good specificity was 90.8–98.44% 35, 36, 37. Of note, comparison of these studies with our data is inherently biased, because the specimens in our study being collected after the initiation of antibiotic treatment (see study design above).
RESULTS
Detection of S. aureus by Means of Real‐Time PCR and Conventional Microbiology
First, a global analysis of positive and negative S. aureus detection by each method was performed (Table 1). The conventional microbiology testing (n = 116 samples) yielded positive results for S. aureus in 32 cases and negative results in 84 cases, while real‐time PCR (n = 116 samples) had positive results for S. aureus in 55 cases and negative results in 61 cases (Table 1).
Table 1.
Detection Results of S. Aureus Obtained by the Conventional Microbiology and by Real‐Time PCR
| Conventional microbiology (n = 116) | Real‐time PCR (n = 116) | |
|---|---|---|
| Positive result | 32 | 55 |
| Negative result | 84 | 61 |
Second, real‐time PCR was cross‐compared to the conventional microbiology (Table 2). Analysis showed that in 26 samples real‐time PCR gave a positive signal despite a negative result in the conventional microbiology procedure. On the other hand, real‐time PCR remained negative in three samples, while the conventional microbiology testing rendered a positive result (Table 2).
Table 2.
Cross‐Classified Table Shows S. Aureus Detection Results of the Conventional Microbiology Versus Real‐Time PCR
| Real‐time PCR negative | Real‐time PCR positive | |
|---|---|---|
| Microbiology negative | 58 | 26 |
| Microbiology positive | 3 | 29 |
Third, findings were evaluated for each patient (Table 3). Immediately after inclusion into the study, six patients were found positive for S. aureus by PCR testing and the conventional microbiology testing, respectively. In five of these six patients, PCR had a higher detection rate for S. aureus than the conventional microbiology. Only in one patient did the conventional microbiology yield more positive results for S. aureus than those obtained by real‐time PCR (Table 3).
Table 3.
Detection of S. Aureus by Real‐Time PCR and the Conventional Microbiology per Patient
| S. aureus detection by PCR | S. aureus detection by convent. microbiology | ||||
|---|---|---|---|---|---|
| Negative | Positive | Negative | Positive | Total number of samples per patients | |
| Patient 1 | 10 | 0 | 10 | 0 | 10 |
| Patient 2 | 3 | 5 | 4 | 4 | 8 |
| Patient 3 | 6 | 0 | 6 | 0 | 6 |
| Patient 4 | 1 | 0 | 1 | 0 | 1 |
| Patient 5 | 2 | 0 | 2 | 0 | 2 |
| Patient 6 | 9 | 25 | 15 | 19 | 34 |
| Patient 7 | 8 | 7 | 12 | 3 | 15 |
| Patient 8 | 9 | 2 | 9 | 2 | 11 |
| Patient 9 | 2 | 0 | 2 | 0 | 2 |
| Patient 10 | 1 | 0 | 1 | 0 | 1 |
| Patient 11 | 2 | 2 | 3 | 1 | 4 |
| Patient 12 | 8 | 14 | 19 | 3 | 22 |
Detection of CoNS by Real‐Time PCR and Conventional Microbiology
Next, global analysis for positive and negative CoNS detection by method was performed (Table 4). The conventional microbiology testing (n = 116 samples) rendered positive results for CoNS in 24 cases and negative results in 92 cases, with real‐time PCR (n = 116 samples) showing positive results for CoNS in 63 samples and negative results in 53 (Table 4).
Table 4.
Detection Results of CoNS Obtained by the Conventional Microbiology and by Real‐Time PCR
| Conventional microbiology (n = 116) | Real‐time PCR (n = 116) | |
|---|---|---|
| Positive result | 24 | 63 |
| Negative result | 92 | 53 |
Second, real‐time PCR was cross‐compared to the conventional microbiology (Table 5). Analysis showed that in 47 samples real‐time PCR yielded positive results for CoNS, while the conventional microbiology testing remained negative. On the other hand, in eight samples real‐time PCR remained negative, while the conventional microbiology testing showed a positive result (Table 5).
Table 5.
Cross‐Classified Table Shows CoNS Detection Results of the Conventional Microbiology Versus Real‐Time PCR
| Real‐time PCR negative | Real‐time PCR positive | |
|---|---|---|
| Microbiology negative | 45 | 47 |
| Microbiology positive | 8 | 16 |
Third, findings were evaluated for each patient (Table 6). Eleven patients were found positive for CoNS with at least one of the detection methods. In 7 of these 11 patients real‐time PCR detected CoNS more often than the conventional microbiology. In two patients the conventional microbiology detected CoNS at a higher rate than real‐time PCR (Table 6). Only one of 12 patients had a continuous negative result for CoNS with both real‐time PCR and the conventional microbiology after inclusion into the study.
Table 6.
Detection of CoNS by Real‐Time PCR and the Conventional Microbiology per Patient
| CoNS detection by PCR | CoNS detection by convent. microbiology | ||||
|---|---|---|---|---|---|
| Negative | Positive | Negative | Positive | Total number of samples per patients | |
| Patient 1 | 3 | 7 | 8 | 2 | 10 |
| Patient 2 | 0 | 8 | 4 | 4 | 8 |
| Patient 3 | 0 | 6 | 5 | 1 | 6 |
| Patient 4 | 0 | 1 | 0 | 1 | 1 |
| Patient 5 | 2 | 0 | 2 | 0 | 2 |
| Patient 6 | 10 | 24 | 28 | 6 | 34 |
| Patient 7 | 13 | 2 | 13 | 2 | 15 |
| Patient 8 | 4 | 7 | 9 | 2 | 11 |
| Patient 9 | 1 | 1 | 2 | 0 | 2 |
| Patient 10 | 1 | 0 | 0 | 1 | 1 |
| Patient 11 | 0 | 4 | 4 | 0 | 4 |
| Patient 12 | 19 | 3 | 17 | 5 | 22 |
Detection of Methicillin Resistance by Real‐Time PCR and Conventional Microbiology
After initial detection and identification of either S. aureus or CoNS, tests for methicillin resistance of the corresponding organisms were conducted. Methillicin resistance detected by real‐time PCR identified by amplification of the mecA gene is reported in Table 7. In all samples that were positive for monoinfection with S. aureus (n = 28) or positive for mixed infections with S. aureus/CoNS (n = 27) according to real‐time PCR, the mecA gene was detected.
Table 7.
MecA Gene Detection in Samples (n = 116) by Real‐Time PCR
| Negative for CoNS and S. aureus | Positive for CoNS | Positive for S. aureus | Positive for CoNS and S. aureus | Total | |
|---|---|---|---|---|---|
| mecA gene negative | 25 | 1 | 0 | 0 | 26 |
| mecA gene positive | 0 | 35 | 28 | 27 | 90 |
Thirty‐six samples were positive for monoinfection with CoNS using real‐time PCR. In 35 of these samples the mecA gene was also detected. In one case a positive result for CoNS was found using real‐time PCR although the mecA gene tested negative (Table 7). None of the samples that tested negative for S. aureus or CoNS via real‐time PCR showed a mecA‐positive result.
Identified samples of S. aureus and CoNS were also tested for methicillin resistance by the conventional microbiological methods. All samples rendered positive by the conventional microbiology for S. aureus (n = 22) or for mixed infection with S. aureus and CoNS (n = 10) were methicillin resistant (Table 8).
Table 8.
MRSA Detected by the Conventional Microbiology
| Positive for S. aureus | Positive for CoNS and S. aureus | |
|---|---|---|
| Methicillin‐sensitive S. aureus | 0 | 0 |
| Methicillin‐resistant S. aureus | 22 | 10 |
DISCUSSION
The occurrence of methicillin‐resistant S. aureus has steadily increased since the introduction of semi‐synthetic penicillins in 1961 (such as methicillin and oxacillin) and their frequent use for therapy of infections caused by S. aureus. Infections by these strains become a serious problem worldwide 5, 6, 7, 38, 39.
In the present study, we tested a fast and easy to use real‐time PCR based method for detection of S. aureus and CoNS in the biological fluids. Moreover, the assay permitted identification of methicillin‐resistant species by detecting the mecA gene. Two consecutive PCR runs were needed and could be performed in 90 min altogether. One vial was needed for each run and sample. It has to be pointed out, that the mecA PCR amplifies the mecA gene from S. aureus as well as from CoNS, and that either can carry mecA. Therefore, in mixed infections it is not possible to determine with this assay, which of the Staphylococcus species is carrying the mecA gene. To meet these concerns, we split the data for analysis into mono‐infected and mixed‐infected samples. Nevertheless, there are strong indications of horizontal gene transfer between CoNS and S. aureus 40, 41, 42, 43, 44, 45. Therefore, mecA‐positive mixed infections of S. aureus and CoNS may be considered to have a higher risk of becoming MRSA positive. One hundred and sixteen clinical samples were tested with this method and compared to the conventional microbiology testing (Table 1).
The real‐time PCR assay identified S. aureus and CoNS in more samples than with the conventional microbiology testing (55 vs. 32 for S. aureus, Table 1; 63 vs. 24 for CoNS, Table 4). Twenty‐six samples with S. aureus detected by PCR were missed by the conventional microbiology testing. The higher detection rate of the molecular testing method is due to the fact that DNA from dead bacteria can still be detected by PCR, while the conventional testing identifies only viable organisms. On the other hand, three samples were missed by PCR but detected with the conventional microbiology (Table 2). All samples that gave a positive result for monoinfection with S. aureus (n = 28) or showed a positive result for mixed infections with S. aureus/CoNS (n = 27) via real‐time PCR also tested positive for the mecA gene (Table 7). There may have been a bias due to the fact that only routinely identified MRSA patients were included into the study. Nonetheless, this analysis could show that the number of CoNS‐positive samples detected by real‐time PCR in comparison to the conventional microbiology testing was surprisingly high. This is likely due to the high sensitivity of PCR. In this context, contamination of the samples during acquisition and during the workflow especially with S. epidermidis must to be considered, even though samples were processed with maximum care to avoid contamination. Nevertheless, the rate of monoinfected mecA‐positive CoNS was also surprisingly high (35 out of 36 samples, Table 7), confirming that not only S. aureus but also CoNS show methicillin resistance to a high degree in patients with nosocomial infections and should be taken into clinical consideration 17, 27, 46, 47.
Moreover, we evaluated the performance of real‐time PCR versus the conventional microbiology with respect to samples per patient. Six patients converted back to being S. aureus/MRSA‐negative upon inclusion into the study . The number of patients initially positive for S. aureus/CoNS who reverted back to negative is not surprising, as these patients were already treated with antibiotics, due to the time that elapsed since initial positive MRSA screening and inclusion into the study. On the other hand, six patients were found still to be positive for S. aureus after inclusion into the study. The fact that some of our MRSA patients remained positive after clinical treatment might be attributed to the organism having resistance to new antibiotics (e.g., Mupirocin). PCR had a significantly higher detection rate than the conventional microbiology in detecting S. aureus (in five vs. one patients, Table 3) and CoNS (seven vs. two patients, Table 6), respectively.
The time that elapses between taking a sample and obtaining a definite result is of great importance and should be minimized. The conventional microbiology testing usually has a delay of 24 to 48 h until microbiological testing results become available 48. Earlier studies using PCR techniques have used rather complicated manual DNA extraction protocols, followed by single or multiplex PCR with detection of amplification products on agarose gels 11, 20, 21, 22, 23, 24, 25, 26, 27. Most of these methods are time consuming, easily susceptible to contamination due to the manual protocols, and largely unsuitable for routine diagnostic laboratories. Previously real‐time PCR for detection of S. aureus and mecA gene has been used 49, 50, 51, 52, 53, 54, but with significant differences. Tan et al. (54) did not employ an internal control; Hope et al. (52) preincubated the samples; Reischl et al. (53) did not test their method in a clinical setting with clinical specimens; and Fang et al. (49) and Hagen et al. (51) used overnight cultivation.
The method we used in this study has a hands‐on time of less than 5 h for preparation of DNA, carrying out PCR, and evaluating its results, speeding up the process considerably compared to the 48 h using the conventional method. Other commercial real‐time PCR assays with similar specifications are available. Among the advantages of this assay are its largely automated nature, easy adaptability, high sensitivity, specificity, and reliability. Hence, detection and differentiation of S. aureus and CoNS including the mecA gene by means of real‐time PCR may accelerate therapeutic decisions and enable even earlier adequate antibiotic treatment.
SK and LEL contributed equally to this project
REFERENCES
- 1. Barber M. Methicillin‐resistant staphylococci. J Clin Pathol 1961;14:385–393. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Jevons MP. Letter. Br Med J 1961;1:124–125. [Google Scholar]
- 3. Rolinson GN. Letter. Br Med J 1961;1:125–126. [Google Scholar]
- 4. Fluckiger U, Widmer AF. Epidemiology of methicillin‐resistant Staphylococcus aureus . Chemotherapy 1999;45:121–134. [DOI] [PubMed] [Google Scholar]
- 5. Bukharie HA, Abdelhadi MS, Saeed IA, Rubaish AM, Larbi EB. Emergence of methicillin‐resistant Staphylococcus aureus as a community pathogen. Diagn Microbiol Infect Dis 2001;40:1–4. [DOI] [PubMed] [Google Scholar]
- 6. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001;7:178–182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998;339:520–532. [DOI] [PubMed] [Google Scholar]
- 8. Chambers HF. Methicillin resistance in staphylococci: Molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997;10:781–791. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Chaix C, Durand‐Zaleski I, Alberti C, Brun‐Buisson C. Control of endemic methicillin‐resistant Staphylococcus aureus: A cost‐benefit analysis in an intensive care unit. JAMA 1999;282:1745–1751. [DOI] [PubMed] [Google Scholar]
- 10. Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis 1999;5:9–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Kohner P, Uhl J, Kolbert C, Persing D, Cockerill F, III . Comparison of susceptibility testing methods with mecA gene analysis for determining oxacillin (methicillin) resistance in clinical isolates of Staphylococcus aureus and coagulase‐negative Staphylococcus spp. J Clin Microbiol 1999;37:2952–2961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Predari SC, Ligozzi M, Fontana R. Genotypic identification of methicillin‐resistant coagulase‐negative staphylococci by polymerase chain reaction. Antimicrob Agents Chemother 1991;35:2568–2573. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Ribeiro J, Vieira FD, King T, D'Arezzo JB, Boyce JM. Misclassification of susceptible strains of Staphylococcus aureus as methicillin‐resistant S. aureus By a rapid automated susceptibility testing system. J Clin Microbiol 1999;37:1619–1620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Ubukata K, Nonoguchi R, Matsuhashi M, Konno M. Expression and inducibility in Staphylococcus aureus of the mecA gene, which encodes a methicillin‐resistant S. aureus‐specific penicillin‐binding protein. J Bacteriol 1989;171:2882–2885. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Chambers HF. Detection of methicillin‐resistant staphylococci. Infect Dis Clin North Am 1993;7:425–433. [PubMed] [Google Scholar]
- 16. Hartman BJ, Tomasz A. Low‐affinity penicillin‐binding protein associated with beta‐lactam resistance in Staphylococcus aureus . J Bacteriol 1984;158:513–516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Kloos WE, Bannerman TL. Update on clinical significance of coagulase‐negative staphylococci . Clin Microbiol Rev 1994;7:117–140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Murakami K, Minamide W, Wada K, Nakamura E, Teraoka H, Watanabe S. Identification of methicillin‐resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol 1991;29:2240–2244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Pierre J, Williamson R, Bornet M, Gutmann L. Presence of an additional penicillin‐binding protein in methicillin‐resistant Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, and Staphylococcus simulans with a low affinity for methicillin, cephalothin, and cefamandole. Antimicrob Agents Chemother 1990;34:1691–1694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Barski P, Piechowicz L, Galinski J, Kur J. Rapid assay for detection of methicillin‐resistant Staphylococcus aureus using multiplex PCR. Mol Cell Probes 1996;10:471–475. [DOI] [PubMed] [Google Scholar]
- 21. Brakstad OG, Aasbakk K, Maeland JA. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J Clin Microbiol 1992;30:1654–1660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Kearns AM, Seiders PR, Wheeler J, Freeman R, Steward M. Rapid detection of methicillin‐resistant staphylococci by multiplex PCR. J Hosp Infect 1999;43:33–37. [DOI] [PubMed] [Google Scholar]
- 23. Martineau F, Picard FJ, Roy PH, Ouellette M, Bergeron MG. Species‐specific and ubiquitous‐DNA‐based assays for rapid identification of Staphylococcus aureus . J Clin Microbiol 1998;36:618–623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Tokue Y, Shoji S, Satoh K, Watanabe A, Motomiya M. Detection of methicillin‐resistant Staphylococcus aureus (MRSA) using polymerase chain reaction amplification. Tohoku J Exp Med 1991;163:31–37. [DOI] [PubMed] [Google Scholar]
- 25. Tokue Y, Shoji S, Satoh K, Watanabe A, Motomiya M. Comparison of a polymerase chain reaction assay and a conventional microbiologic method for detection of methicillin‐resistant Staphylococcus aureus . Antimicrob Agents Chemother 1992;36:6–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Unal S, Hoskins J, Flokowitsch JE, Wu CY, Preston DA, Skatrud PL. Detection of methicillin‐resistant staphylococci by using the polymerase chain reaction. J Clin Microbiol 1992;30:1685–1691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. York MK, Gibbs L, Chehab F, Brooks GF. Comparison of PCR detection of mecA with standard susceptibility testing methods to determine methicillin resistance in coagulase‐negative staphylococci . J Clin Microbiol 1996;34:249–153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Bekkaoui F, McNevin JP, Leung CH, et al. Rapid detection of the mecA gene in methicillin resistant staphylococci using a colorimetric cycling probe technology. Diagn Microbiol Infect Dis 1999;34:83–90. [DOI] [PubMed] [Google Scholar]
- 29. Cloney L, Marlowe C, Wong A, Chow R, Bryan R. Rapid detection of mecA in methicillin resistant Staphylococcus aureus using cycling probe technology. Mol Cell Probes 1999;13:191–197. [DOI] [PubMed] [Google Scholar]
- 30. Hussain Z, Stoakes L, Lannigan R, Longo S, Nancekivell B. Evaluation of screening and commercial methods for detection of methicillin resistance in coagulase‐negative staphylococci . J Clin Microbiol 1998;36:273–274. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Jureen R, Bottolfsen KL, Grewal H, Digranes A. Comparative evaluation of a commercial test for rapid identification of methicillin‐resistant Staphylococcus aureus . APMIS 2001;109:787–790. [DOI] [PubMed] [Google Scholar]
- 32. Kolbert CP, Arruda J, Varga‐Delmore P, et al. Branched‐DNA assay for detection of the mecA gene in oxacillin‐resistant and oxacillin‐sensitive staphylococci. J Clin Microbiol 1998;36:2640–2644. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Vannuffel P, Laterre PF, Bouyer M, et al. Rapid and specific molecular identification of methicillin‐resistant Staphylococcus aureus in endotracheal aspirates from mechanically ventilated patients. J Clin Microbiol 1998;36:2366–2368. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Wallet F, Roussel‐Delvallez M, Courcol RJ. Choice of a routine method for detecting methicillin‐resistance in staphylococci. J Antimicrob Chemother 1996;37:901–909. [DOI] [PubMed] [Google Scholar]
- 35. Levi K, Towner KJ. Rapid detection of methicillin‐resistant Staphylococcus aureus from screening enrichment broths by real‐time PCR. Eur J Clin Microbiol Infect Dis 2005;24:423–427. [DOI] [PubMed] [Google Scholar]
- 36. Malhotra‐Kumar S, Haccuria K, Michiels M, et al. Current trends in rapid diagnostics for methicillin‐resistant Staphylococcus aureus and glycopeptide‐resistant enterococcus species. J Clin Microbiol 2008;46:1577–1587. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Shrestha NK, Tuohy MJ, Padmanabhan RA, Hall GS, Procop GW. Evaluation of the LightCycler Staphylococcus M GRADE kits on positive blood cultures that contained gram‐positive cocci in clusters. J Clin Microbiol 2005;43:6144–6146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Panlilio AL, Culver DH, Gaynes RP, et al. Methicillin‐resistant Staphylococcus aureus in U.S. hospitals, 1975–1991. Infect Control Hosp Epidemiol 1992;13:582–586. [DOI] [PubMed] [Google Scholar]
- 39. Voss A, Milatovic D, Wallrauch‐Schwarz C, Rosdahl VT, Braveny I. Methicillin‐resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994;13:50–55. [DOI] [PubMed] [Google Scholar]
- 40. Archer GL, Pennell E. Detection of methicillin resistance in staphylococci by using a DNA probe. Antimicrob Agents Chemother 1990;34:1720–1724. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Archer GL, Niemeyer DM, Thanassi JA, Pucci MJ. Dissemination among staphylococci of DNA sequences associated with methicillin resistance. Antimicrob Agents Chemother 1994;38:447–454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Brakstad OG, Maeland JA. Mechanisms of methicillin resistance in staphylococci. APMIS 1997;105:264–276. [DOI] [PubMed] [Google Scholar]
- 43. Hanssen AM, Kjeldsen G, Sollid JU. Local variants of Staphylococcal cassette chromosome mec in sporadic methicillin‐resistant Staphylococcus aureus and methicillin‐resistant coagulase‐negative staphylococci: Evidence of horizontal gene transfer? Antimicrob Agents Chemother 2004;48:285–296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Musser JM, Kapur V. Clonal analysis of methicillin‐resistant Staphylococcus aureus strains from intercontinental sources: Association of the mec gene with divergent phylogenetic lineages implies dissemination by horizontal transfer and recombination. J Clin Microbiol 1992;30:2058–2063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Wielders CL, Vriens MR, Brisse S, et al. In‐vivo transfer of mecA DNA to Staphylococcus aureus [corrected]. Lancet 2001;357:1674–1675. [DOI] [PubMed] [Google Scholar]
- 46. Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis 2001;32(Suppl 2):S114–S132. [DOI] [PubMed] [Google Scholar]
- 47. Jarlov JO. Phenotypic characteristics of coagulase‐negative staphylococci: Typing and antibiotic susceptibility. APMIS Suppl 1999;91:1–42. [PubMed] [Google Scholar]
- 48. Kumar Y, Qunibi M, Neal TJ, Yoxall CW. Time to positivity of neonatal blood cultures. Arch Dis Child Fetal Neonatal Ed 2001;85:F182–F186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Fang H, Hedin G. Rapid screening and identification of methicillin‐resistant Staphylococcus aureus from clinical samples by selective‐broth and real‐time PCR assay. J Clin Microbiol 2003;41:2894–2899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Grisold AJ, Leitner E, Muhlbauer G, Marth E, Kessler HH. Detection of methicillin‐resistant Staphylococcus aureus and simultaneous confirmation by automated nucleic acid extraction and real‐time PCR. J Clin Microbiol 2002;40:2392–2397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Hagen RM, Seegmuller I, Navai J, Kappstein I, Lehn N, Miethke T. Development of a real‐time PCR assay for rapid identification of methicillin‐resistant Staphylococcus aureus from clinical samples. Int J Med Microbiol 2005;295:77–86. [DOI] [PubMed] [Google Scholar]
- 52. Hope WW, Morton AP, Looke DF, Schooneveldt JM, Nimmo GR. A PCR method for the identification of methicillin‐resistant Staphylococcus aureus (MRSA) from screening swabs. Pathology 2004;36:265–268. [DOI] [PubMed] [Google Scholar]
- 53. Reischl U, Linde HJ, Metz M, Leppmeier B, Lehn N. Rapid identification of methicillin‐resistant Staphylococcus aureus and simultaneous species confirmation using real‐time fluorescence PCR. J Clin Microbiol 2000;38:2429–2433. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Tan TY, Corden S, Barnes R, Cookson B. Rapid identification of methicillin‐resistant Staphylococcus aureus from positive blood cultures by real‐time fluorescence PCR. J Clin Microbiol 2001;39:4529–4531. [DOI] [PMC free article] [PubMed] [Google Scholar]
